Assam health ministry Himanta Biswa Sarma (File photo)
GUWAHATI: Assam on Friday enter play with the’test-track-treat’ plan for early detection and containment of this Covid-19 pandemic using a point-of-care rapid antigen test, which can be fast, easy, secure and will creep up the evaluation capacities.
Assam health minister Himanta Biswa Sarma tweeted,”At a shot in the arm to our attempts to test, monitor and cure #Covid19 sufferers, I am rather pleased to share that we have got two lakh Quick Point of Care Antigen Detection Evaluation kits, a brand new instrument accepted by @ICMRDELHI for fast identification of SARS-CoV-2 in area settings.”
The ICMR advisory on Quick Point-of-Care (PoC) Antigen Detection Evaluation says,”Since the whole public health machines is focused on examine, monitor and treat Covid-19 patients, it is vital to research the present antigen-based assays as point-of-care evaluations for early detection of SARS-CoV-2.”
“A positive evaluation ought to be deemed as a true positive whereas most of symptomatic people analyzing negative throughout the rapid antigen test ought to be verified using a real-time PCR evaluation,” the advisory states.
ICMR and AIIMS, Delhi have independently evaluated the standalone quick point of care antigen detection assay, which will not need a technical machine and may be translated using a nude eye and thus empowers taxpayers for analyzing for SARS-CoV-2virus.
“The evaluation is a promising instrument for fast identification of SARS-CoV-2 in area settings. The assay is referred to as Conventional Q Covid-19 Ag kit also has been invented by SD Biosensor with manufacturing unit in Manesar, Gurugram. On empowerment, the evaluation was discovered to have an extremely higher specificity with average sensitivity. It’s currently suggested to use Standard Q Covid-19 Ag detection evaluation for a point of care diagnostic assay for analyzing from the containment zones in addition to hospitals together with the golden standard RT-PCR evaluation,” that the ICMR probate adds.
ICMR has advocated deployment of the rapid antigen PoC evaluation in most containment zones characterized by the state authorities, state and central government medical schools and government hospitals, all private hospitals accepted by National Accreditation Board for Hospitals & Healthcare (NABH) and all personal labs accredited by National Accreditation Board for Laboratories (NABL) and accepted by ICMR as Covid-19 testing labs.
The ICMR has included that hospitals, labs, country authorities intending to execute the PoC antigen test have to enroll with ICMR to acquire the login credentials for information entry.